apparent diffusion coefficient adc (Siemens Healthineers)
Structured Review
Apparent Diffusion Coefficient Adc, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apparent+diffusion+coefficient+(adc)+maps/adc+apparent+coefficient+diffusion/pmc11264621-80-22-27
Average 86 stars, based on 1 article reviews
Images
Related Articles
Imaging:Article Title: Diagnostic performance of magnetic resonance imaging features to differentiate adrenal pheochromocytoma from adrenal tumors with positive biochemical testing results Article Snippet: MRI was performed at a single tertiary care referral center using one of three clinical 3-T systems (Symphony or TRIO, Siemens Healthcare or Discovery 750 W, General Electric Healthcare). .. All prebiopsy magnetic resonance images, consisting of T1 weighted imaging, T2-weighted imaging and T2-SPAIR (Spectral Attenuated Inversion Recovery) imagine, diffusion-weighted imaging, and Diffusion-based Assay:Article Title: Diagnostic performance of magnetic resonance imaging features to differentiate adrenal pheochromocytoma from adrenal tumors with positive biochemical testing results Article Snippet: MRI was performed at a single tertiary care referral center using one of three clinical 3-T systems (Symphony or TRIO, Siemens Healthcare or Discovery 750 W, General Electric Healthcare). .. All prebiopsy magnetic resonance images, consisting of T1 weighted imaging, T2-weighted imaging and T2-SPAIR (Spectral Attenuated Inversion Recovery) imagine, diffusion-weighted imaging, and |

![FIGURE 2 (A) Representative images obtained in one rat at 3 h following the MCAo. The <t>ADC</t> map depicts the core of ischemia (arrow). The time-to-peak map reveals a larger zone of hypoperfusion (arrow). The penumbra was delineated as the mismatch between perfusion and diffusion abnormalities (hatched purple). The StO2-MRI map shows the area with reduced oxygen saturation (arrow). [18F]-FMISO-PET delineates the hypoxic area with increased retention of [18F]-FMISO (arrow). The T2-W image, acquired 24 h after the MCAo, shows the consolidated lesion (arrow). (B) Evolution of ADC-defined lesion volumes. The lesion demonstrable at 15 min expanded at 3 h, and even more so at 24 h following the MCAo. **p < 0.01; ***p < 0.001; ANOVA with repeated measures followed by Tukey's post hoc test. The boxes define the interquartile range; the solid horizontal line the median, and the whiskers represent the minimal and maximal values. (C) Volumes of brain compartments at 3 h following the MCAo. Time-to-peak (TTP): tissue volume with decreased perfusion; Penumbra: tissue with PWI/DWI mismatch; StO2-MRI: tissue that displays a decrease in oxygen saturation; [18F]-FMISO-PET: tissue volume that shows an increased retention of [18F]-FMISO. The boxes define the interquartile range; the solid horizontal line the median and the whiskers represent the minimal and maximal values. ADC, apparent diffusion <t>coefficient;</t> ANOVA, analysis of variance; DWI, diffusion-weighted imaging; MCAo, middle cerebral artery occlusion; PET, positron emission tomography; PWI, perfusion-weighted imaging; StO2-MRI, magnetic resonance-based imaging of brain oxygen saturation; T2-W, T2-weighted; [18F]-FMISO, 18-fluorine-fluoromisonidazole](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_5719/pm36285719/pm36285719__page5_image1.jpg)